Fate Therapeutics
FATE
#7575
Rank
A$0.41 B
Marketcap
$3.64
Share price
-7.03%
Change (1 day)
16.58%
Change (1 year)

EPS for Fate Therapeutics (FATE)

EPS in 2023 (TTM): -$3.27

According to Fate Therapeutics 's latest financial reports the company's current EPS (TTM) is -$3.32. In 2022 the company made an earnings per share (EPS) of -$4.46 a decrease over its 2021 EPS that were of -$3.42.

EPS history for Fate Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.27-26.6%
2022-$4.4630.49%
2021-$3.427.21%
2020-$3.1945.45%
2019-$2.1919.17%
2018-$1.8417.65%
2017-$1.56-3.77%
2016-$1.62-12.4%
2015-$1.85-3.97%
2014-$1.93-2.09%
2013-$1.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$11.99 260.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.50-355.76%๐Ÿ‡บ๐Ÿ‡ธ USA
-$13.25 298.62%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.75 42.86%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.00-190.32%๐Ÿ‡บ๐Ÿ‡ธ USA